0000000000305915
AUTHOR
Robert Sackstein
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
The Collaborative Working Group “Noma Project Team”.
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
[This corrects the article DOI: 10.3389/fimmu.2019.01151.].